封面
市場調查報告書
商品編碼
1535111

全球胃鏡市場 - 市場規模(依細分市場)、佔有率、法規、償付、治療、運行設備數量、預測(~2033年)

Gastroscopes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures, Installed Base and Forecast to 2033

出版日期: | 出版商: GlobalData | 英文 | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

本報告研究和分析了全球胃鏡市場,提供了有關主要參與者、市場佔有率、主要趨勢、創新產品和技術以及競爭格局的資訊。

市場模型的主要內容如下。

已上市的胃鏡和不斷變化的競爭格局

  • 對主要產業趨勢的考察
  • 依細分市場劃分的胃鏡市場年收入和市場前景(2015-2033年)
  • 依細分市場劃分的總營業量、單位數量、平均售價和市場價值的詳細資料

全球、區域和國家層面的特定市場考察

  • 依地區細分全球趨勢的特定市場定性資訊和國家考察
  • 胃鏡市場的SWOT分析
  • 胃鏡市場競爭動態的考察與趨勢

透過對醫療保健系統的真實、全面的了解來促進市場理解。市場進入部分還提供有關償付政策和監管環境的訊息,能夠更深入地研究市場動態。

  • 各國醫療保健系統概覽
  • 依國家/地區劃分的償付政策
  • 各國醫療科技監理狀況

目標公司

  • Ambu Inc
  • Olympus Corp
  • Fujifilm Holdings Corp
  • PENTAX Medical Co
  • KARL STORZ SE & Co KG
  • SonoScape Medical Corp
  • Shanghai Aohua Photoelectricity Endoscope Co Ltd
  • Medigus Ltd
  • 其他
簡介目錄
Product Code: GDME801MM

Gastroscopes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures, Installed Base and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Endoscopy Devices therapeutic area.

Gastroscopes are also known as Esophagogastroduodenoscopes (EGD)/Oesophagogastroduodenoscopes (OEGD). Gastroscopes are forward-viewing endoscopes with insertion tubes designed primarily for visualization of oesophagus, stomach and duodenum.

Gastroscopes are used in a variety of diagnostic and therapeutic procedures associated with the upper gastrointestinal tract. Diagnostic procedures include the detection of peptic ulcers, gastroesophageal reflux disease (GERD), coeliac disease, stomach cancer. Various surveillance and screening studies are easily carried out using gastroscopes. Therapeutic interventional gastroscopy includes procedures for acute, as well as chronic diseases in the gastrointestinal tract.

Each of the covered 39 countries color-coded and fully-sourced market models is equipped with epidemiology-based indications with procedure volumes and installed base. The interactive Excel deliverable covers the installed base, new sales volumes, product usage, average selling prices, market size, and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Gastroscopes and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Gastroscopes market revenue by segment and market outlooks from 2015-2033.
  • Granular data on the total installed base, units, average selling prices, and market values by segment.

Global, Regional, and Country level market specific insights -

  • Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • SWOT analysis for the Gastroscopes market.
  • Competitive dynamics insights and trends provided for the Gastroscopes market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country-specific overview of the healthcare system.
  • Country-specific reimbursement policies.
  • Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Ambu Inc, Olympus Corp, Fujifilm Holdings Corp, PENTAX Medical Co, KARL STORZ SE & Co KG, SonoScape Medical Corp, Shanghai Aohua Photoelectricity Endoscope Co Ltd, Medigus Ltd, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Gastroscopes marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
  • Develop business strategies by understanding the trends shaping and driving Gastroscopes market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Gastroscopes market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Gastroscopes market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.